Editorial: The EXCEL Trial

Código QR

Editorial: The EXCEL Trial

Guardado en:

Detalles Bibliográficos
Autores principales:	Pablo Avanzas, Juan Carlos Kaski
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/646fa874f8204c8d8428696ceee85fb6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The ISCHEMIA Trial: And the Winner Is… the Patient
por: Pablo Avanzas, et al.
Publicado: (2021)

The EXCEL Trial: The Interventionalists’ Perspective
por: George William Hunter, et al.
Publicado: (2021)

The EXCEL Trial: The Surgeons’ Perspective
por: Marjan Jahangiri, et al.
Publicado: (2020)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Foreword
por: Juan Carlos Kaski
Publicado: (2019)

Foreword
por: Juan Carlos Kaski
Publicado: (2019)

Foreword
por: Juan Carlos Kaski
Publicado: (2019)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
por: Ramón Arroyo-Espliguero, et al.
Publicado: (2021)

Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
por: Talla A Rousan, et al.
Publicado: (2019)

Porcelain aorta rupture after cardiopulmonary resuscitation
por: Iria Silva, et al.
Publicado: (2021)

Porcelain aorta rupture after cardiopulmonary resuscitation
por: Iria Silva, et al.
Publicado: (2021)

ISCHEMIA Trial: Key Questions and Answers
por: Jose Lopez-Sendon, et al.
Publicado: (2021)

The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials
por: Danielle Haanschoten, et al.
Publicado: (2021)

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
por: Ricardo Lopez Santi, et al.
Publicado: (2021)

Editorial Board Page
Publicado: (2021)

The ISCHEMIA Trial: What is the Message for the Interventionalist?
por: Emmanuel Ako, et al.
Publicado: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials
por: Ahmadreza Karimianpour, et al.
Publicado: (2021)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)

What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?
por: Islam Y Elgendy, et al.
Publicado: (2020)

Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial
por: Suzanne J Baron
Publicado: (2020)

Evolution of the Editorial Board Underpins a Commitment to Change and Innovation
por: Demosthenes G Katritsis
Publicado: (2020)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Ernest Spitzer, et al.
Publicado: (2020)

Background and Proposed Design for a Metformin Abdominal Aortic Aneurysm Suppression Trial
por: Ronald L Dalman, et al.
Publicado: (2020)

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
por: Ernest Spitzer, et al.
Publicado: (2019)

TCT Connect 2020 Trial Update: FORECAST, COMBINE OCT-FFR and DEFINE-PCI
por: Kevin Cheng, et al.
Publicado: (2021)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
por: Jonathan Yap, et al.
Publicado: (2021)

Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Sheng-Lin Ye MD, et al.
Publicado: (2021)

Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
por: Kelly H Schlendorf, et al.
Publicado: (2020)

Electrophysiology’s Identity Crisis: What our Clinical Trials Do and Do Not Say About Us
por: David J Callans, et al.
Publicado: (2020)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

BEST Endovascular Versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) Trial
por: Raghu Motaganahalli, et al.
Publicado: (2020)

An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
por: Mustafa Kılıçkap, et al.
Publicado: (2021)

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Qian Zeng, et al.
Publicado: (2021)

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021)

Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention: Evidence from Observational Studies and Randomized Controlled Trials
por: Xiao-Fei Gao, et al.
Publicado: (2020)

What is the Real Message of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial for Academic and Practising Cardiologists?
por: Kreton Mavromatis, et al.
Publicado: (2020)

Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)